Chimeric hepatitis A virus particles presenting a foreign epitope (HIV gp41) at their surface

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Hepatitis A virus (HAV) protein 2A is implicated in virus assembly and potentially located on the virion surface.
• Investigating protein 2A's potential as a display platform for foreign epitopes on HAV particles is crucial for vaccine development.

Purpose of the Study:

• To engineer chimeric Hepatitis A virus (HAV) particles capable of presenting foreign antigenic epitopes on their surface.
• To assess the suitability of the HAV 2A protein domain as a scaffold for displaying heterologous epitopes.

Main Methods:

• Construction of a full-length HAV cDNA encoding a chimeric protein incorporating a human immunodeficiency virus type 1 (HIV-1) gp41 epitope.
• Expression of the chimeric cDNA in mammalian cells (COS7, Huh-T7) using vaccinia virus MVA-T7.
• Characterization of produced chimeric particles using immunospecific enzyme-linked immunosorbent assay (ELISA) and immunoelectron microscopy.

Main Results:

• Chimeric HAV particles displaying the HIV-1 gp41 epitope on their surface were successfully produced.
• These particles were identified as empty capsids (70S) through sucrose gradient analysis and electron microscopy.
• Immunological detection confirmed the presence of the gp41 epitope on the VP1-2A protein of the chimeric HAV particles.

Conclusions:

• The 2A domain of Hepatitis A virus is suitable for presenting foreign antigenic epitopes.
• Engineered HAV particles can serve as a platform for displaying heterologous epitopes, with potential applications in vaccine design.
• This study validates the use of HAV as a potential carrier for foreign antigens.